Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone and triamterene for blood pressure reduction in oligo-anuric hemodialysis patients
NL-OMON36327Recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of spironolactone and triamterene in hypertension (HTN) (3 arms), sponsored by Maasstad Ziekenhuis. Primary endpoint: Change in predialysis systolic blood pressure. Started Mar 2011; status: recruiting.
02
Drugs
spironolactonetriamterene
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON36327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36327.